Recently, the albumin-bilirubin (ALBI) score, a new non-invasive tool to evaluate liver function and predict survival in HCC patients [14], showed promising results in predicting the long-term prognosis of chronic liver disease [15] and HCC patients [16], including PHLF prediction. This evidence concerns the gene ALB and hepatocellular carcinoma.